Your browser doesn't support javascript.
loading
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
Ikizler, T Alp; Coates, P Toby; Rovin, Brad H; Ronco, Pierre.
  • Ikizler TA; Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: alp.ikizler@vumc.org.
  • Coates PT; Centre for Clinical and Experimental Transplantation, The University of Adelaide, Adelaide, Australia.
  • Rovin BH; Internal Medicine-Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Ronco P; Unité Mixte de Recherche S 1155, Sorbonne Université, Université Pierre et Marie Curie Paris 06 and Institut National de la Santé et de la Recherche Médicale, Paris, France; Division of Nephrology, Centre Hospitalier du Mans, Le Mans, France.
Kidney Int ; 99(6): 1275-1279, 2021 06.
Article en En | MEDLINE | ID: mdl-33931226
ABSTRACT
In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest that there is durability of immune response after COVID-19 infection. Although immune response to the first dose of vaccine is less in infection-naïve patients than healthy individuals in both groups, after the second vaccine dose a significant portion of patients receiving maintenance dialysis develop robust antibody titers, whereas kidney transplant recipients show a less-strong immune response.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diálisis Renal / Trasplante de Riñón / Vacunas contra la COVID-19 / COVID-19 Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diálisis Renal / Trasplante de Riñón / Vacunas contra la COVID-19 / COVID-19 Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article